Works matching High dose rate brachytherapy

Results: 2055
    1
    2
    3
    4
    5

    The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10851-0
    By:
    • Mendez, Lucas C.;
    • Dhar, Aneesh;
    • Laidley, David;
    • Moussa, Madeleine;
    • Gomez, Jose A.;
    • Chin, Joseph;
    • Lee, T-Y;
    • Thiessen, Jonathan D.;
    • Hoover, Douglas;
    • Surrey, Kathleen;
    • Helou, Joelle;
    • Velker, Vikram;
    • Correa, Rohann J.;
    • D'Souza, David;
    • Bayani, Jane;
    • Bauman, Glenn
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Minimally invasive tumor bed implant (MITBI) and peri-operative high-dose-rate brachytherapy (PHDRBT) for accelerated minimal breast irradiation (AMBI) or anticipated boost (A-PHDRBT-boost) in breast-conserving surgery for ductal carcinoma in situ.

    Published in:
    Journal of Contemporary Brachytherapy, 2020, v. 12, n. 6, p. 521, doi. 10.5114/jcb.2020.101684
    By:
    • Morales, Marta Gimeno;
    • Martinez-Regueira, Fernando;
    • Rodriguez-Spiteri, Natalia;
    • Olartecoechea, Begoña;
    • Rubio, Isabel;
    • Esgueva, Antonio;
    • Pina, Luis;
    • Elizalde, Arlette;
    • Sampedro, Carolina Sobrido;
    • Idoate, Miguel Angel;
    • Abengozar, Marta;
    • Ramos, Luis;
    • Manuel, Felipe Calvo;
    • Martínez-Monge, Rafael;
    • Cambeiro, Mauricio
    Publication type:
    Article
    12

    A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer.

    Published in:
    Journal of Contemporary Brachytherapy, 2019, v. 11, n. 6, p. 573, doi. 10.5114/jcb.2019.91225
    By:
    • Ken Yoshida;
    • Tadayuki Kotsuma;
    • Hironori Akiyama;
    • Hideya Yamazaki;
    • Tadashi Takenaka;
    • Koji Masui;
    • Yutaka Tsujimoto;
    • Naoya Murakami;
    • Yasuo Uesugi;
    • Taiju Shimbo;
    • Nobuhiko Yoshikawa;
    • Hiroto Yoshioka;
    • Mio Nakata;
    • Takumi Arika;
    • Yuji Takaoka;
    • Eiichi Tanaka;
    • Nikolaos Tselis
    Publication type:
    Article
    13
    14
    15
    16

    Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy.

    Published in:
    Journal of Contemporary Brachytherapy, 2014, v. 6, n. 2, p. 154, doi. 10.5114/jcb.2014.43299
    By:
    • Gomez-Iturriaga, Alfonso;
    • Crook, Juanita;
    • Casquero, Francisco;
    • Carvajal, Claudia;
    • Urresola, Arantxa;
    • Canteli, Begoña;
    • Ezquerro, Ana;
    • Hortelano, Eduardo;
    • Cacicedo, Jon;
    • Espinosa, Jose Maria;
    • Perez, Fernando;
    • Minguez, Pablo;
    • Bilbao, Pedro
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    Sociodemographic and clinicopathologic characteristics of patients treated with high dose rate prostate brachytherapy in Nigeria.

    Published in:
    Ecancermedicalscience, 2024, v. 18, n. 1706-1753, p. 1, doi. 10.3332/ecancer.2024.1740
    By:
    • Abdus-Salam, Abbas A.;
    • Jimoh, Mutiu A.;
    • Folasire, Ayorinde M.;
    • Ntekim, Atara I.;
    • Ojo, Olabisi T.;
    • Ehiedu, Chiamaka G.;
    • Yusuf, Sikiru A.;
    • Takure, Augustine O.;
    • Akinlade, Bidemi I.;
    • Idowu, Olusola K.;
    • Oladeji, Afolabi A.;
    • Sarimiye, Foluke O.;
    • Adenipekun, Adeniyi A.
    Publication type:
    Article
    25
    26
    27
    28

    Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1200, doi. 10.1007/s10147-023-02383-1
    By:
    • Miyajima, Keiichiro;
    • Suzuki, Hirotaka;
    • Urabe, Fumihiko;
    • Iwatani, Kosuke;
    • Imai, Yu;
    • Yasue, Keiji;
    • Yanagisawa, Takafumi;
    • Kimura, Shoji;
    • Tashiro, Kojiro;
    • Tsuzuki, Shunsuke;
    • Koike, Yusuke;
    • Miki, Jun;
    • Yuen, Steffi;
    • Sasaki, Takaya;
    • Aoki, Manabu;
    • Sato, Shun;
    • Takahashi, Hiroyuki;
    • Miki, Kenta;
    • Kimura, Takahiro
    Publication type:
    Article
    29

    The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1092, doi. 10.1007/s10147-023-02359-1
    By:
    • Kadena, Soshi;
    • Urabe, Fumihiko;
    • Iwatani, Kosuke;
    • Suzuki, Hirotaka;
    • Imai, Yu;
    • Tashiro, Kojiro;
    • Tsuzuki, Shunsuke;
    • Honda, Mariko;
    • Koike, Yusuke;
    • Shimomura, Tatsuya;
    • Aoki, Manabu;
    • Sato, Shun;
    • Takahashi, Hiroyuki;
    • Miki, Kenta;
    • Kimura, Takahiro
    Publication type:
    Article
    30
    31

    The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2310, doi. 10.1007/s10147-021-02023-6
    By:
    • Makino, Tomoyuki;
    • Sakurai, Takayuki;
    • Takamatsu, Shigeyuki;
    • Iwamoto, Hiroaki;
    • Yaegashi, Hiroshi;
    • Iijima, Masashi;
    • Kawaguchi, Shohei;
    • Nohara, Takahiro;
    • Shigehara, Kazuyoshi;
    • Izumi, Kouji;
    • Kadono, Yoshifumi;
    • Mizokami, Atsushi
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50